Viewing Study NCT04606303


Ignite Creation Date: 2025-12-24 @ 7:25 PM
Ignite Modification Date: 2025-12-25 @ 5:05 PM
Study NCT ID: NCT04606303
Status: UNKNOWN
Last Update Posted: 2023-04-05
First Post: 2020-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC.
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module